Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 135.66M P/E - EPS this Y 37.00% Ern Qtrly Grth -
Income -40.16M Forward P/E -11.76 EPS next Y 50.00% 50D Avg Chg -7.00%
Sales 34.72M PEG -0.33 EPS past 5Y - 200D Avg Chg -19.00%
Dividend N/A Price/Book 3.05 EPS next 5Y 20.00% 52W High Chg -53.00%
Recommedations 1.80 Quick Ratio 2.88 Shares Outstanding 67.83M 52W Low Chg 8.00%
Insider Own 14.27% ROA -27.51% Shares Float 39.78M Beta 1.60
Inst Own 63.76% ROE -87.06% Shares Shorted/Prior 454.55K/504.81K Price 2.00
Gross Margin 95.02% Profit Margin -115.67% Avg. Volume 316,124 Target Price 5.00
Oper. Margin -123.23% Earnings Date Oct 27 Volume 682,525 Change 1.52%
About Strongbridge Biopharma plc

As of October 5, 2021, Strongbridge Biopharma plc was acquired by Xeris Pharmaceuticals, Inc. Strongbridge Biopharma plc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs in the United States. The company offers Keveyis, an oral carbonic anhydrase inhibitor to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis. Its clinical-stage product candidates include Recorlev, a cortisol synthesis inhibitor, which is in Phase III clinical trials for the treatment of endogenous Cushing's syndrome; and Veldoreotide, a somatostatin analog that has completed Phase II clinical trial for the treatment of acromegaly. The company was formerly known as Cortendo plc and changed its name to Strongbridge Biopharma plc in September 2015. Strongbridge Biopharma plc was founded in 1996 and is based in Trevose, Pennsylvania.

SBBP Chatroom

User Image risenhoover Posted - 03/26/23

$SBBP SBBP / Strongbridge Biopharma plc Price Target Updated https://fintel.io/sfo/us/sbbp?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/25/23

$SBBP SBBP / Strongbridge Biopharma plc Price Target Updated https://fintel.io/sfo/us/sbbp?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/24/23

$SBBP SBBP / Strongbridge Biopharma plc Price Target Updated https://fintel.io/sfo/us/sbbp?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/23/23

$SBBP SBBP / Strongbridge Biopharma plc Price Target Updated https://fintel.io/sfo/us/sbbp?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/21/23

$SBBP SBBP / Strongbridge Biopharma plc Price Target Updated https://fintel.io/sfo/us/sbbp?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/20/23

$SBBP SBBP / Strongbridge Biopharma plc Price Target Updated https://fintel.io/sfo/us/sbbp?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/19/23

$SBBP SBBP / Strongbridge Biopharma plc Price Target Updated https://fintel.io/sfo/us/sbbp?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/17/23

$SBBP SBBP / Strongbridge Biopharma plc Price Target Updated https://fintel.io/sfo/us/sbbp?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/16/23

$SBBP SBBP / Strongbridge Biopharma plc Price Target Updated https://fintel.io/sfo/us/sbbp?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/15/23

$SBBP SBBP / Strongbridge Biopharma plc Price Target Updated https://fintel.io/sfo/us/sbbp?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/13/23

$SBBP SBBP / Strongbridge Biopharma plc Price Target Updated https://fintel.io/sfo/us/sbbp

User Image dave2ta Posted - 03/13/23

@Gety @NobVega I was there for that CRL and cashed out too. I actually used that money to get into $SBBP, which is now $XERS . I got back into it months ago figuring they would finally get FDA approval, which they did, but the SP didn't move much. I decided to just put it aside and hope a buyout would come. It actually came a little sooner than I thought but I'm not complaining... đź‘Ť

User Image LionFox Posted - 01/30/23

$XERS do we know when FDA designated Recorlev an orphan drug? I’m guessing before Xeris bought $SBBP Not when it was approved (December 30, 2021) Not today, when it was granted Orphan Drug Exclusivity

User Image nomoney82742 Posted - 10/12/22

$XERS any $SBBP people still here lmao

User Image LionFox Posted - 08/10/22

@acinvestor13 clearly the more valuable products…currently. $SBBP saw behind the curtain on the collabs and technology so they must have seen something promising that was worth the wait. We shall see.

User Image LionFox Posted - 1 year ago

@BarbarianConan do you remember if the merger documents produced for the $SBBP merger show the TAM for EEA?

User Image dave2ta Posted - 04/19/22

@Ripstick27 good question. As a $SBBP holder, I wonder what our SP would be if we didn't line up with Xers? I thought at the time that it was a good paring for both companies, and I still do. As long as we continue to sell products and expand our customer base, I think we will all be happy.

User Image macroaxis Posted - 03/17/22

$SBBP - Option Volatility signal: Strongbridge Biopharma pin risk is declining https://www.macroaxis.com/stock-options/SBBP/Strongbridge-Biopharma-Plc?utm_source=dlvr.it&utm_medium=stocktwits

User Image bigwhalealert Posted - 03/07/22

$SBBP BUY/SELL METER NOW Change 12% + 🚀 https://t8sk.com/SBBP

User Image bigwhalealert Posted - 02/24/22

$SBBP TA Stats Today's Change 41% + 🚀 https://t8sk.com/SBBP

User Image bigwhalealert Posted - 02/15/22

$SBBP TA Stats Today's Change 93% + 🚀 https://t8sk.com/SBBP

User Image c_sonnier Posted - 02/15/22

$XERS @BeeeeDooooh So I combined the Q3 $SBBP filings, calculated the conversion, and compared with the latest Q4 $XERS filings. I removed CALL & PUT rows along with 0’s,

User Image cctranscripts Posted - 02/11/22

OrbiMed Advisors LLC just issued a filing suggesting it has sold all of its Strongbridge Biopha https://www.conferencecalltranscripts.com/summary/?id=10436948 $SBBP

User Image PennySearch Posted - 02/07/22

$SBBP JMP Securities gave SBBP a Market Perform stock rating on 2021-05-25. Find top penny stocks with PennySearch before the moon launch. https://play.google.com/store/apps/details?id=org.invescent.pennysearch&hl=en_US&gl=US

User Image dave2ta Posted - 02/07/22

@Jrevord The big number for me is $2.36... That's where my $SBBP shares break even. A lot of my buys of Xers are in the Green now from Averaging down though...

User Image PennySearch Posted - 02/06/22

$SBBP JMP Securities gave SBBP a Market Perform stock rating on 2021-05-25. Find top penny stocks with PennySearch before the moon launch. https://play.google.com/store/apps/details?id=org.invescent.pennysearch&hl=en_US&gl=US

User Image PennySearch Posted - 2 years ago

$SBBP JMP Securities gave SBBP a Market Perform stock rating on 2021-05-25. Find top penny stocks with PennySearch before the moon launch. https://play.google.com/store/apps/details?id=org.invescent.pennysearch&hl=en_US&gl=US

User Image bigwhalealert Posted - 01/27/22

$SBBP Twits Stats Today's Change 93% + 🚀 https://t8sk.com/SBBP

User Image c_sonnier Posted - 01/14/22

$XERS Form SC 13G Stonepine Capital, aka Timothy Lynch, 6,491,099 shares. They owned 3,566,964 shares of $SBBP This mean Stonepine added 3,694,599 shares since their 5% ownership of $SBBP 6,491,099-(3,566,964*0.7840)=3,694,599 https://www.sec.gov/Archives/edgar/data/0001440771/000093583622000016/xeris13g_.htm

User Image UncleRicoQB1 Posted - 01/12/22

@Quaternity That's primarily because $XERS acquired $SBBP and its two FDA (now) approved revenue generating drugs for $267M in May 2021. How many shares did that require?

Analyst Ratings
Craig-Hallum Hold May 25, 21
JMP Securities Market Perform May 25, 21
HC Wainwright & Co. Buy Oct 30, 20
Craig-Hallum Buy Mar 3, 20
Oppenheimer Outperform Feb 26, 20
Evercore ISI Group Outperform Sep 25, 19
Jefferies Buy Sep 24, 19
Laidlaw & Co. Buy Dec 18, 18
Cantor Fitzgerald Overweight Aug 9, 18
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
- - - Sep 21 Buy 2.23 1,479,377 3,299,011 8,060,682 09/21/20